Share this postChina Daily ReadsAlibaba, WuXi Biologics lead Hong Kong stock rebound on fund inflows, Fed rate focusCopy linkFacebookEmailNotesMoreAlibaba, WuXi Biologics lead Hong Kong stock rebound on fund inflows, Fed rate focusMainland investors were net buyers of HK$11.6 billion worth of Alibaba shares since it became an eligible component in the Stock Connect scheme this weekSep 12, 2024∙ PaidShare this postChina Daily ReadsAlibaba, WuXi Biologics lead Hong Kong stock rebound on fund inflows, Fed rate focusCopy linkFacebookEmailNotesMoreShareThis post is for paid subscribersAlready a paid subscriber? Sign in